What is Veracyte's R&D?

Veracyte (VCYT) reported R&D of $27.1M in Q1 2026.

How has Veracyte's R&D changed year-over-year?

Veracyte's R&D increased by 52.9% year-over-year, from $17.72M to $27.1M.

What is the long-term trend for Veracyte's R&D?

Over 4 years (2021 to 2025), Veracyte's R&D has grown at a 24.1% compound annual growth rate (CAGR), from $29.84M to $70.81M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Veracyte VCYT R&D

R&D at other companies

Guardant HealthGH

$91.04M+2.8%

Natera, Inc.NTRA

$210.7M+63.2%

Bio-Rad LaboratoriesBIO

$62.9M-14.4%

RevvityRVTY

$57.89M+8.0%

Agilent TechnologiesA

$126M+12.5%

Idexx LaboratoriesIDXX

$65.79M+11.4%

Segments

By segment

See full

Reportable Segment$27.1M+52.9%

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's R&D?: Veracyte (VCYT) reported R&D of $27.1M in Q1 2026.
How has Veracyte's R&D changed year-over-year?: Veracyte's R&D increased by 52.9% year-over-year, from $17.72M to $27.1M.
What is the long-term trend for Veracyte's R&D?: Over 4 years (2021 to 2025), Veracyte's R&D has grown at a 24.1% compound annual growth rate (CAGR), from $29.84M to $70.81M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.